LLLoïc Legris

Loïc Legris

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Loïc Legris has a total of 183 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Implementation and validation of a clinically compatible four-shell diffusion MRI protocol for ischemic stroke research

    by Emmanuelle Gourieux, Johan Pietras, Aurélien Delphin, Loic Legris, Alexandre Krainik, Olivier Detante, Assia Jaillard

  • Symmetrical Deep Gray Matter Hemorrhage Through the Canal of Gratiolet

    by Alexandre Thiebaut, Stéphane Charara, Isabelle Favre-Wiki, Loïc Legris

  • VesselVerse: A Dataset and Collaborative Framework for Vessel Annotation

    by Daniele Falcetta, Vincenzo Marciano, Kaiyuan Yang, Jon Cleary, Loïc Legris, Massimiliano Domenico Rizzaro, Ioannis Pitsiorlas, Hava Chaptoukaev, Benjamin Lemasson, Bjoern Menze, et al.


  • Relaxometry and contrast‐free cerebral microvascular quantification using balanced steady‐state free precession MR fingerprinting

    by Thomas Coudert, Aurélien Delphin, Antoine Barrier, Loïc Legris, Jan M. Warnking, Laurent Lamalle, Mariya Doneva, Benjamin Lemasson, Emmanuel L. Barbier, Thomas Christen

    Purpose: This study proposes a novel, contrast‐free Magnetic Resonance Fingerprinting (MRF) method using balanced Steady‐State Free Precession (bSSFP) sequences for the quantification of cerebral blood volume (CBV), vessel radius (R), and relaxometry parameters (T, T, T*) in the brain. Methods: The technique leverages the sensitivity of bSSFP sequences to intra‐voxel frequency distributions in both transient and steady‐state regimes. A dictionary‐matching process is employed, using simulations of realistic mouse microvascular networks to generate the MRF dictionary. The method is validated through in silico and in vivo experiments on six healthy subjects, comparing results with standard MRF methods and literature values. Results: The proposed method shows strong correlation and agreement with standard MRF methods for T and T values. High‐resolution maps provide detailed visualizations of CBV and microvascular structures, highlighting differences in white matter (WM) and gray matter (GM) regions. The measured GM/WM ratio for CBV is 1.91, consistent with literature values. Conclusion: This contrast‐free bSSFP‐based MRF method offers an new approach for quantifying CBV, vessel radius, and relaxometry parameters. Further validation against DSC imaging and clinical studies in pathological conditions is warranted to confirm its clinical utility.


  • Open Access

    Penumbral Rescue by normobaric O = O administration in patients with ischemic stroke and target mismatch proFile (PROOF): Study protocol of a phase IIb trial

    by Sven Poli, Joshua Mbroh, Jean-Claude Baron, Aneesh B Singhal, Daniel Strbian, Carlos Molina, Robin Lemmens, Guillaume Turc, Robert Mikulik, Patrik Michel, et al.

    Rationale: Oxygen is essential for cellular energy metabolism. Neurons are particularly vulnerable to hypoxia. Increasing oxygen supply shortly after stroke onset could preserve the ischemic penumbra until revascularization occurs. Aims: PROOF investigates the use of normobaric oxygen (NBO) therapy within 6 h of symptom onset/notice for brain-protective bridging until endovascular revascularization of acute intracranial anterior-circulation occlusion. Methods and design: Randomized (1:1), standard treatment-controlled, open-label, blinded endpoint, multicenter adaptive phase IIb trial. Study outcomes: Primary outcome is ischemic core growth (mL) from baseline to 24 h (intention-to-treat analysis). Secondary efficacy outcomes include change in NIHSS from baseline to 24 h, mRS at 90 days, cognitive and emotional function, and quality of life. Safety outcomes include mortality, intracranial hemorrhage, and respiratory failure. Exploratory analyses of imaging and blood biomarkers will be conducted. Sample size: Using an adaptive design with interim analysis at 80 patients per arm, up to 456 participants (228 per arm) would be needed for 80% power (one-sided alpha 0.05) to detect a mean reduction of ischemic core growth by 6.68 mL, assuming 21.4 mL standard deviation. Discussion: By enrolling endovascular thrombectomy candidates in an early time window, the trial replicates insights from preclinical studies in which NBO showed beneficial effects, namely early initiation of near 100% inspired oxygen during short temporary ischemia. Primary outcome assessment at 24 h on follow-up imaging reduces variability due to withdrawal of care and early clinical confounders such as delayed extubation and aspiration pneumonia. Trial registrations: ClinicalTrials.gov: NCT03500939; EudraCT: 2017-001355-31.


  • Endovascular Therapy or Medical Management Alone for Isolated Posterior Cerebral Artery Occlusion: A Multicenter Study

    by Candice Sabben, Frédérique Charbonneau, François Delvoye, Davide Strambo, Mirjam R. Heldner, Elodie Ong, Adrien Ter Schiphorst, Hilde Henon, Wagih Ben Hassen, Thomas Agasse-Lafont, et al.

    Background: Whether endovascular therapy (EVT) added on best medical management (BMM), as compared to BMM alone, is beneficial in acute ischemic stroke with isolated posterior cerebral artery occlusion is unknown. Methods: We conducted a multicenter international observational study of consecutive stroke patients admitted within 6 hours from symptoms onset in 26 stroke centers with isolated occlusion of the first (P1) or second (P2) segment of the posterior cerebral artery and treated either with BMM+EVT or BMM alone. Propensity score with inverse probability of treatment weighting was used to account for baseline between-groups differences. The primary outcome was 3-month good functional outcome (modified Rankin Scale [mRS] score 0–2 or return to baseline modified Rankin Scale). Secondary outcomes were 3-month excellent recovery (modified Rankin Scale score 0–1), symptomatic intracranial hemorrhage, and early neurological deterioration. Results: Overall, 752 patients were included (167 and 585 patients in the BMM+EVT and BMM alone groups, respectively). Median age was 74 (interquartile range, 63–82) years, 329 (44%) patients were female, median National Institutes of Health Stroke Scale was 6 (interquartile range 4–10), and occlusion site was P1 in 188 (25%) and P2 in 564 (75%) patients. Baseline clinical and radiological data were similar between the 2 groups following propensity score weighting. EVT was associated with a trend towards lower odds of good functional outcome (odds ratio, 0.81 [95% CI, 0.66–1.01]; P =0.06) and was not associated with excellent functional outcome (odds ratio, 1.17 [95% CI, 0.95–1.43]; P =0.15). EVT was associated with a higher risk of symptomatic intracranial hemorrhage (odds ratio, 2.51 [95% CI, 1.35–4.67]; P =0.004) and early neurological deterioration (odds ratio, 2.51 [95% CI, 1.64–3.84]; P <0.0001). Conclusions: In this observational study of patients with proximal posterior cerebral artery occlusion, EVT was not associated with good or excellent functional outcome as compared to BMM alone. However, EVT was associated with higher rates of symptomatic intracranial hemorrhage and early neurological deterioration. EVT should not be routinely recommended in this population, but randomization into a clinical trial is highly warranted.


  • Lorsque la carotide tombe sur un os !

    by Sami El Mimouni, Stéphane Charara, Christol Fabre, Olivier Detante, Loïc Legris

  • Direct admission of stroke in MRI room reduces in-hospital delays and improves recovery

    by L. Legris, S. Grand, M. Roustit, V. Brenckmann, I. Favre-Wiki, O. Detante, J. Papassin

  • Open Access

    Pearls & Oy-sters: De Novo Seizure and Stroke in the Elderly

    by Christo Bratanov, Loïc Legris, Guillaume Martin

    Seizures immediately preceding the occurrence of an ischemic or hemorrhagic stroke are a rare but well documented phenomenon, for which the term “heraldic seizure” has been proposed. Cerebrovascular disease is the most common cause of epileptic seizures in elderly patients, thus screening and management of vascular risk factors should be done systematically in cases of late-onset epilepsy. MRI may help to distinguish heraldic seizure from stroke-elicited seizure by showing abnormalities confined to the cortex that spare vascular territories, increased MRA flow in the ipsilateral cerebral arteries and enhancement of the leptomeninges on postcontrast MRI. Here we present a case report that illustrates the difficulty of making the diagnosis of a heraldic seizure at onset.


  • Post-infectious relapsing encephalomyelitis due to toxocara canis

    by L. Legris, J. Papassin, O. Cognet, G. Besson, O. Casez